Anktiva Prices, Coupons, Copay Cards & Patient Assistance
Anktiva (nogapendekin alfa inbakicept) is a member of the miscellaneous antineoplastics drug class and is commonly used for Bladder Cancer.
The cost for Anktiva (pmln 400 mcg/0.4 mL) intravesical solution is around $38,227 for a supply of 0.4 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Anktiva prices
Intravesical Solution
pmln 400 mcg/0.4 mL
Anktiva intravesical solution
from $38,227.22
for 0.4 milliliters
Quantity | Per unit | Price |
---|---|---|
0.4 milliliters | $95,568.05 | $38,227.22 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Anktiva Coupons, Copay Cards and Rebates
Anktiva offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Anktiva Copay Program
Eligible commercially insured patients may pay as little as $100 per dose; providers may enroll their patient by faxing the form to 833-462-4329.
- Applies to:
- Anktiva
- Number of uses:
- Per calendar year
Form more information phone: 833-462-4329 or Visit website
Patient Assistance & Copay Programs for Anktiva
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Anktiva (nogapendekin alfa inbakicept-pmln) Solution; Intravesical
More information please phone: 866-316-7263 Visit Website
Provider: ImmunityBio Care
Eligibility requirements:- Determined case by case
- Based on FPL
- FDA-approved diagnosis
- Must be treated by US licensed healthcare provider
- Anktiva (nogapendekin alfa inbakicept-pmln) Solution; Intravesical
More information please phone: 833-422-2731 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Padcev
Padcev (enfortumab vedotin) is an antibody-drug conjugate that is given as an intravenous infusion ...
Platinol
Platinol is used for bladder cancer, blood cell transplantation, bone marrow transplantation, brain ...
Enfortumab vedotin
Enfortumab vedotin systemic is used for bladder cancer, urothelial carcinoma
Mitomycin
Mitomycin systemic is used for anal cancer, bladder cancer, pancreatic cancer, stomach cancer ...
Durvalumab
Durvalumab (Imfinzi) is an immunotherapy used to treat lung cancer (NSCLC, SCLC) and other cancers ...
Doxorubicin
Doxorubicin systemic is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder ...
More about Anktiva (nogapendekin alfa inbakicept)
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español